
|Articles|July 29, 2022
- July 2022
- Volume 88
- Issue 7
Pet Peeves: July 2022
Brought to you by The Sassy Pharmacist
Advertisement
Shrouded in Mystery
After you ring out the prescriptions and give to the patient they ask “so what did I get here?”
DIY
Patients who ask the pharmacist to go online to schedule a COVID-19 test or vaccine for them.
Not a Refill Request
The pharmacist sends the physician the prior authorization rejection and then gets a script for the same thing.
What’s Bothering You?
Bossy patients, abandoned prescriptions, drive-through demands? We want to know! Send your pet peeves to cmollison@pharmacytimes.com. We’ll share them here and online.
Articles in this issue
over 4 years ago
National Practitioner Data Bank Aims to Reduce Malpracticeover 4 years ago
July 2022: Generic Product Newsover 4 years ago
Pharmacists Can Help Manage Patients With Parkinson Diseaseover 4 years ago
Quviviq From Idorsia Pharmaceuticalsover 4 years ago
OTC Case Studies: Rhinitisover 4 years ago
July 2022: Rx Product Newsover 4 years ago
Know Your Salary Rangeover 4 years ago
Help Patients Use Inhalers Properlyover 4 years ago
Illinois Legislature Empowers Pharmacistsover 4 years ago
Board’s Licensure Revocations Are Upheld on AppealAdvertisement
Related to this article

Safe storage and responsible disposal help protect patients from accidental poisoning and drug misuse while keeping medications stable and effective.

Pharmacists can help identify uncontrolled risk factors, review medications, and reinforce when patients should seek emergency care.

The anti-CD20 antibody is the first drug approved specifically for the disease, based on phase 3 MAJESTY data showing higher remission vs tacrolimus.

From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.

Christie Ballantyne, MD, says high extension enrollment and a single 20-mg daily dose are encouraging signs for patient adherence to oral enlicitide.

An ASRA-recognized quality improvement project draws attention to injectate reproducibility, offering a starting point for examining medication preparation and pharmacists’ role in safer pain procedures.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dexmedetomidine Receives FDA Approval for Acute Treatment for Agitation Associated With Schizophrenia
2
Giredestrant Plus Everolimus Wins FDA Approval in ESR1-Mutated Advanced Breast Cancer
3
Blood Glucose Testing: When Nonadherence Isn't the Real Issue
4
FDA Approves Gefurulimab as First Once-Weekly, Self-Administered C5 Inhibitor for gMG
5


